Pluri (PLUR) Equity Average (2011 - 2025)
Pluri (PLUR) reported Equity Average of -$7.4 million for Q4 2025, down 398.66% year-over-year from $2.5 million in Q4 2024, and down 18.98% quarter-over-quarter from -$6.2 million in Q3 2025.
Pluri (PLUR) Equity Average (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Equity Average data on file, last reported at -$7.4 million in Q4 2025.
- Equity Average for Q4 2025 came in at -$7.4 million, down 398.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.4 million (down 398.66% YoY), and the FY2025 annual result was -$713500.0, down 106.89% from the prior year.
- Equity Average slipped to -$7.4 million in Q4 2025 per PLUR's latest filing, from -$6.2 million in the prior quarter.
- Over five years, Equity Average peaked at $62.6 million in Q2 2021 and troughed at -$7.4 million in Q4 2025.
- A 5-year average of $19.8 million and a median of $15.6 million in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2021 and 2025: Equity Average jumped 263.32% in 2021, then slumped 398.66% in 2025.
- A 5-year view of Equity Average shows it stood at $44.4 million in 2021, then tumbled by 41.56% to $25.9 million in 2022, then sank by 65.96% to $8.8 million in 2023, then slumped by 116.88% to -$1.5 million in 2024, then tumbled by 398.66% to -$7.4 million in 2025.
- Business Quant data shows PLUR's Equity Average at -$7.4 million in Q4 2025, -$6.2 million in Q3 2025, and -$5.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 516.41 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.43 Mn |
| Sep 30, 2025 | -6.24 Mn |
| Jun 30, 2025 | -5.66 Mn |
| Mar 31, 2025 | -3.70 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Dec 31, 2023 | 8.83 Mn |
| Sep 30, 2023 | 13.17 Mn |
| Jun 30, 2023 | 18.09 Mn |
| Mar 31, 2023 | 22.92 Mn |
| Dec 31, 2022 | 25.93 Mn |
| Sep 30, 2022 | 29.54 Mn |
| Jun 30, 2022 | 36.16 Mn |
| Mar 31, 2022 | 39.99 Mn |
| Dec 31, 2021 | 44.37 Mn |
| Sep 30, 2021 | 53.03 Mn |
| Jun 30, 2021 | 62.64 Mn |
| Mar 31, 2021 | 54.64 Mn |